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a  b  s  t  r  a  c  t
Aim: The aim of this study was to formulate isodose volume relations encompassed by iso-
dose  surfaces in Co-60 and Ir-192 HDR intracavitary brachytherapy (ICBT) of cervix carcinoma
using  the Total Reference Air Kerma (TRAK).
Background: The TRAK and isodose volumes are radioactive source related. The formulated
relations can easily estimate the irradiated isodose volume if the TRAK and dose are known.
The C0-60 can also be used for brachytherapy because of its longer half life and comparable
OAR  doses to Ir-192.
Materials and methods: Isodose volumes encompassed by different isodose surfaces and TRAK
were obtained from 22 Ca cervix ICBT treatment plans in Co-60 and Ir-192 HDR brachytherapy
with 9 Gy prescription to point A. Isodose volume relations were formulated both for Co-60
and Ir-192 brachytherapy source from the slopes and intercepts of the linear fit in the plot
between isodose volumes and TRAKs.
Results: The TRAK value of Co-60 was higher than Ir-192 by about 7.16%. The isodose volumes
at  low doses for Co-60 were higher than Ir-192. But no significant differences in the dose
to  the bladder and rectum were observed due to these sources. For dose to 2 cm3 bladder
and rectum volume, the differences were 1.07% and 0.75%, respectively. The correlation
coefficient with the 2-tailed significance of correlation (p value) between TPS measured
isodose volume and calculated isodose volumes using the formulated relations at differentdose  values were statistically significant as p < 0.05.
Conclusion: Results show different isodose volumes for both sources but the dose to the
bladder and rectum are nearly the same.
er Po
range therapy and has been described as the first form of©  2019 Great
1.  BackgroundBrachytherapy is a radiation therapy technique in which
radioisotopes are placed very close to the tumour. The word
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brachytherapy was derived from Greek. It refers to a shorthanrpc@nitkkr.ac.in (R.P. Chauhan),
in (B. Rai).
conformal radiation therapy.1 The advantages of placing radi-
ation sources very close to the tumour are to deliver a very
high radiation dose to the tumour and very low radiation
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ose to the normal tissue due to its rapid dose fall off. This
s the aim of radiotherapy. So, it is very important to know
he tissue volume encompassed by isodose surfaces of var-
ous doses, particularly of prescription dose and low doses.
arlier, some authors have studied the relationship between
sodose volume and Total Reference Air Kerma (TRAK). The
RAK is the sum of the products of the reference air kerma
ate and the irradiation time for each source. It is an impor-
ant quantity which should be reported for all brachytherapy
pplications. It is a quantity that is simple to calculate and on
hich there can be no ambiguity. It is analogous to the mil-
igram hour (mg.hr) of radium.2 Authors, like Wilkinson and
amachandran, DD Deshpande et al. and NR Datta et al. gave


























here TRAK is in mGy.  m2 and dose in Gy.
Eqs. 1 and 2 were derived for Cs-137 source used in the Low
ose Rate (LDR) brachytherapy whereas Eq. 3 was for the Ir-192
ource in the High Dose Rate (HDR) brachytherapy. Nowadays,
ost of the LDR brachytherapy units in different hospitals
ave been replaced with HDR brachytherapy units. The most
ommonly used radioisotopes of HDR brachytherapy units
vailable in the market at present are Ir-192 and Co-60. The Co-
0 emits gamma photons of average energy 1.25 MeV which
re highly penetrating. It has specific gamma  ray constant of
3.2 R-cm2/hr-mCi. Whereas Ir-192 emits gamma photons of
verage energy 0.38 MeV  with specific gamma  ray constant 4.8
-cm2/hr-mCi. So Co-60 requires more  shielding because of
ts higher photon energy compared to Ir-192. For example, the
quilibrium TVL of Co-60 and Ir-192 are, respectively, 210 mm
nd 139 mm of concrete.11 The advantage of Co-60 over Ir-
92 lies in the logistical aspect as Co-60 has a longer half-life
5.26 years) compared to Ir-192 (73.83 days). Hence, during the
seful life of Co-60, which is its one half-life, about 20 source
xchanges are required for the Ir-192 source.12 Apart from this,
t is also necessary to know the amount of normal tissue vol-
me  irradiated by these sources, particularly at low doses. The
elations mentioned above cannot be applied for all types of
adioactive sources used in brachytherapy. For example, the
sodose volume due to Co-60 radioactive source used in BEBIG
DR MultiSource cannot be estimated using the above rela-
ions (Eqs. 1–3). It is because the volume encompassed by a
articular isodose surface is dependent upon the TRAK. This
an be seen from Fig. 1 that the TRAK value of Co-60 is more
han the Ir-192 source when all the plans were made with the
ame prescription dose of 9 Gy to point A and the same pat-
ern of source loading. So, there are requirements of different
elations based on the type of radioactive source used.therapy 2 4 ( 2 0 1 9 ) 568–575 569
2.  Aim
The aim of this study was to formulate isodose volume rela-
tions encompassed by isodose surfaces in Co-60 and Ir-192
HDR intracavitary brachytherapy (ICBT) of cervix carcinoma
using the Total Reference Air Kerma (TRAK).
3.  Materials  and  methods
For the study, CT series of twenty-two (22) patients were
selected from the database of the treatment planning sys-
tem (TPS, HDR Plus version 3.0.6.0 of Eckert and Ziegler BEBIG,
Germany). The patients underwent intracavitory applications
for cancer of uterine cervix in Co-60 HDR brachytherapy (Multi-
Source, Eckert and Ziegler BEBIG, Germany). All these patients
were treated with the prescription of 9 Gy (normalised to point
A) per fraction in two fractions. Depending upon the length
of the tandem (Fletcher suit), the source loading was differ-
ent and depending upon the source loading and length of the
applicator, the Total Reference Air Kermas (TRAKs) were also
different. The sources were loaded in a step size of 2.5 mm with
default offset value of 4.8 mm.  We  followed our departmental
source loading protocol. For example, the tandem and ovoids
loading pattern for the 6 cm tandem was 1,3,5,7,9,12,15,18, 21,
24; 3,4,5,6; 3,4,5,6. The TRAK values (in cGy.m2) and isodose
volumes encompassed by 3 Gy, 5 Gy, 8 Gy, 9 Gy, 10 Gy, 13 Gy,
15 Gy, 18 Gy, 23 Gy, 25 Gy, 40 Gy and 50 Gy isodose surfaces were
recorded from all the 22 treatment plans from the HDR Plus
TPS. The same CT datasets of these 22 patients were exported
from the Co-60 HDR Plus TPS and imported in the Ir-192 HDR
TPS (Oncentra, version 4.3 of Nucletron, Netherlands). Then
they were used to make similar plans with the same pattern
of source loading and prescription dose in the Oncentra TPS
as those in Co-60 HDR Plus TPS. From the TPS, TRAK values
and isodose volumes encompassed by 3 Gy, 5 Gy, 8 Gy, 9 Gy,
10 Gy, 13 Gy, 15 Gy, 18 Gy and 25 Gy isodose surface were also
recorded from all the 22 plans. Those TRAK values from both
TPS were compared and the comparison was shown in Fig. 1
using Microsoft excel. The isodose volumes encompassed by
different isodose surfaces (Fig. 2) and the dose to 0.1 cm3 and
2 cm3 of the bladder and rectum volumes were compared
(Fig. 3) for both sources. From the collected data, scatter plots
were made between the TRAK and isodose volumes for Co-60
and Ir-192 from both TPS (Fig. 4). All the data points in the
plots followed the linear pattern at different dose values. In
these two plots of Fig. 4, the best fitted curves were the equa-
tions of lines with different slopes and intercepts depending
upon the dose values. Also, the slopes and intercepts of these
fitted lines of different dose values followed a certain pattern.
They were found to be increased with doses. If the slope and
intercept of a particular dose value is known then it would be
possible to find out the isodose volume encompassed by that
particular isodose surface. To find the relationship of slope
and intercept with dose for both the sources, plots of dose
vs. slopes and dose vs. intercepts were made (Fig. 5). Using
MATLAB curve fitting tool, the best fitted curve of these four
plots was found out and it was found to be a power func-
tion curve. The equations of these power function curves that
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Fig. 1 – The comparison of TRAK values for Co-60 and Ir-192 sources from 22 HDR ICBT plans of Ca cervix.
Fig. 2 – Comparison of average isodose volumes of 22 treatment plans at different dose values of Co-60 and Ir-192 sources
ed to
To check the accuracy of the above equations, ten ICBTs of
Ca cervix plans were selected at random from both Oncentrawith the isodose volume difference when 9 Gy was prescrib
relate slopes and intercepts as function of dose are given in
Table 1.
So, the generalised equations of the isodose volume of both
sources were given as:
Isodose volume (cm3) = Slope × TRAK – Intercept
Case 1(Co-60 source):
Isodosevolume(cm3) = (8641×dose−1.709)




where TRAK is in cGy. m2 and dose in Gy.and HDR Plus TPS. From those plans the TRAK values and iso-
dose volumes encompassed by various isodose surfaces were
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Fig. 3 – The isodose comparison between Co-60 and Ir-192 HDR brachytherapy sources. The inset figures A, B and C were of
Co-60, Ir-192 and composite of the two at isodose level 200%, 100%, 50% and 25%.
Fig. 4 – The mean and standard deviation dose at 2 cm3 and 0.1 cm3 volumes of bladder and rectum from 22 ICBT of Ca
cervix treatment plans due to Co-60 and Ir-192 HDR brachytherapy sources (Inset figures A and B for bladder and rectum
respectively).
Fig. 5 – The plots of TRAK and isodose volumes for Co-60 and Ir-192 sources and the regression lines with governing
equations.
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Fig. 6 – Fitted curves of the plots between dose vs slope and dose vs intercept for Co-60 and Ir-192 sources from regression
lines in Fig. 3.
Table 1 – Fitted relations of slope and intercept as a function of dose for both Co-60 and Ir-192 sources from Fig. 4.
Slope Intercept
Co-60 f(x) = a1*xb̂1, where x = dose in Gyfigure*
Coefficients (with 95% confidence
bounds):figure* a1 = 8641 (7512, 9770)figure*
b1 = -1.709 (-1.809, -1.608)figure* Goodness of
fit:figure* SSE: 5098figure* R-square:
0.9966figure* Adjusted R-square:
0.9963figure* RMSE: 22.58
f(x)  = a2*xb̂2, where x = dose in Gyfigure* Coefficients
(with 95% confidence bounds):figure* a2 = 1801 (1409,
2192)figure* b2 = -1.754 (-1.923, -1.585)figure* Goodness
of fit:figure* SSE: 517.9figure* R-square: 0.9911figure*
Adjusted R-square: 0.9902figure* RMSE: 7.196
Ir-192 f(x) = a3*xb̂3, where x = dose in Gyfigure*
Coefficients (with 95% confidence
bounds):figure* a3 = 6621 (6384, 6858)figure*
b3 = -1.594 (-1.621, -1.567)figure* Goodness of
f(x)  = a4*xb̂4, where x = dose in Gyfigure* Coefficients
(with 95% confidence bounds):figure* a4 = 1872 (1483,
2261)figure* b4 = -1.876 (-2.042, -1.71)figure* Goodness
of fit:figure* SSE: 198.9figure* R-square: 0.9957figure*fit:figure* SSE: 204.9figure* R-square:
0.9998figure* Adjusted R-square:
0.9998figure* RMSE: 5.41
recorded. The isodose volumes so obtained from the two TPS
were compared to those obtained using the above two rela-
tions (Eqs. 4 and 5).
4.  Results
From the Fig. 1 it was found that on an average Co-60 has
higher TRAK values with respect to Ir-192 by about 7.16%. Also,
the isodose volumes at low doses were higher in the case of
Co-60 compare to Ir-192. The average of 3 Gy isodose volume
of the 22 treatment plans in Co-60 was about 152.70 cm3 more
than Ir-192. This difference in the isodose volume between
Co-60 and Ir-192 decreased at a higher dose isodose volume
(Fig. 2).
The isodose comparison of the two sources is shown in
Fig. 3. The inset figures A, B and C of it were, respectively, ofAdjusted R-square: 0.9951figure* RMSE: 5.33
Co-60, Ir-192 and composite of the two. Fig. 4 shows the dose to
0.1 cm3 and 2 cm3 bladder and rectum volume due to the two
different types of sources. Reporting of doses to these volumes
is recommended according to many  authors.3,7–10 The doses to
2 cm3 bladder due to the Co-60 and Ir-192 sources were 8.49 Gy
and 8.34 Gy, respectively, while to 0.1 cm3 they were 12.32 Gy
and 11.72 Gy, respectively. Similarly, for the same volumes and
sources, the doses to the rectum were 4.60 Gy, 4.33 Gy, 6.20 Gy
and 5.73 Gy, respectively. In the two plots between TRAK and
isodose volumes of different doses, the best fitted curves were
found to be the lines (Fig. 5). The inset figures show the equa-
tions of these lines of both sources for different dose values.
The slopes and intercepts of these fitted lines of both sources
decrease with the increase in dose. The slopes were more  in
the case of Co-60 than the Ir-192 source for the same dose
value and it appeared that it converged to zero at a very high






























































































































































































































































































































































































































































































































































































































































































































































































































































reports of practical oncology and 
ose. The plots of dose vs. slope and dose vs. intercepts of
he fitted lines are shown in the Fig. 6. Then the best fitted
urves of these plots were found to be of power law relations
Table 1, Fig. 6). The values of isodose volume of various dose
anges (low to high) calculated using the above derived rela-
ions were comparable with those obtained in the respective
PS (Oncentra for Ir-192 and HDR Plus for Co-60). Tables 2 and 3
how the comparison between calculated isodose volumes
sing the above relations and the TPS estimated isodose vol-
mes of ten randomly selected patient treatment plans from
oth TPS. It was found that the percentage deviations of these
sodose volumes calculated using the derived relations from
he TPS isodose volumes increases with the increase in dose.
he average (mean) of the percentage errors with standard
eviations (SD) for the doses 3 Gy, 9 Gy, 15 Gy and 20 Gy were
espectively −1.59 ± 1.32%, −1.84 ± 3.22%, −2.64 ± 4.62% and
1.11 ± 12.87% for the Co-60 source and for the Ir-192 source
or the doses 3 Gy, 9 Gy, 15 Gy and 18 Gy, the average of per-
entage errors was −0.06 ± 0.44%, −2.19 ± 0.46%, 3.15 ± 1.57%
nd 6.96 ± 2.58%, respectively. The correlation coefficient with
-tailed significance of correlation (p value) between TPS mea-
ured and calculated (fitted) isodose volumes in the above
ose values were, respectively, 0.998 (0.000), 0.988 (0.000), 0.986
0.000) and 0.933 (0.000) for Co-60 and 0.998 (0.000), 0.997
0.000), 0.972 (0.000) and 0.94 (0.000) for the Ir-192 sources.
hese correlations were statistically significant as the 2-tailed
ignificance value p < 0.05 (Table 2 and 3)
.  Discussion
gure1, which shows the TRAK value comparison of the Co-
0 and Ir-192 sources for the brachytherapy plans with the
ame pattern of source loading and applicator type, suggests
hat TRAK value is source related and Co-60 has a relatively
igher TRAK value than Ir-192 by about 7.16%. The isodose
olume encompassed by any dose value of Co-60 is higher
han that of the Ir-192 isodose volume encompassed by the
ame dose value (Fig. 2). This difference of the isodose vol-
me  between these two isotopes was significantly larger at
ow dose. At 3 Gy, the difference was about 152.70 cm3. Hence,
he amount of normal tissue volume irradiated at low dose will
e more  in the case of Co-60 as compared to the Ir-192 source.
he isodose of Ir-192 has dips towards the tip of the tandem
hile isodose of Co-60 do not have such feature (Fig. 3). This
ould be one of the factor for higher isodose volume of Co-60
ompare to Ir-192. But the differences in the isodose volume
ue to these sources did not contribute a significant differ-
nce in the bladder and rectal dose (Fig. 4). The mean doses
rom the 22 treatment plans to 2 cm3 bladder volume were
.49 Gy and 8.34 Gy respectively for Co-60 and Ir-192 which is
ust 1.79% higher than the Ir-192 source. Similarly for the rec-
um, the mean doses were, respectively, 4.60 Gy and 4.33 Gy
or Co-60 and Ir-192. For 0.1 cm3 the differences in the dose
o these organs due to these sources were about 0.6 Gy for
he bladder and 0.27 Gy for the rectum. But the isodose vol-
me relation using TRAK must be a source related one and
elations derived from a particular source cannot accurately
ell the isodose volume due to a different source. In Wilkin-
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authors formulated isodose volume relations for Cs-137 used
in LDR brachytherapy.4,5 Their relations are generalised and
applicable for all dose ranges. In NR Datta et al. study, the
authors formulated isodose volume relations for the Ir-192
source used in HDR brachytherapy of ICBT of ca cervix and
the isodose volume converge to negative value at a higher
dose.6 However, isodose volumes cannot be negative. Also, in
their study they compared their results with those of Wilkin-
son and Ramachandran and Deshpande DD et al. studies. The
comparison will not give appropriate results as the relations
were derived for a different radioactive brachytherapy source.
Co-60 as a HDR brachytherapy source has recently been intro-
duced in the market and there is no such relation to estimate
the isodose volume. So, there is a need to formulate an iso-
dose volume relation for Co-60 and the Ir-192 source that is
applicable for all the dose values. In our study we  formulated
generalised isodose volume relations for both the Co-60 and
Ir-192 radioactive sources used in brachytherapy (relations 4
and 5).The slopes and intercepts of the regression line in the
plot between isodose volume and TRAK for both the sources
are source and dose dependent (Fig. 4). For a given dose value,
the slope of Co-60 is more  than the Ir-192 source and the slopes
decreases with the increase in dose. As mentioned above, the
fitted curve using MATLAB of the scatter plots between dose
vs. slope and dose vs. intercepts followed power law relations
(Fig. 5). The coefficient adjusted R-square of the fitted curve in
dose vs. slope for the Co-60 and Ir-192 sources were respec-
tively 0.9963 and 0.9998. Similarly, for dose vs. intercepts the
values were 0.9902 and 0.9951, respectively, for the Co-60 and
Ir-192 sources (Table1). The generalised isodose volume rela-
tions (in cm3) derived using the slopes and intercepts followed
power law (Eqs. 4 and 5). These relations were dose and TRAK
dependent. The isodose volumes calculated using the above
derived relations for ten patient plans, each for both sources,
matched accurately with those measured from the TPS.
6.  Conclusion
The TRAK is source dependent and hence the isodose vol-
ume  relations using it are radioactive source related and are
different for different brachytherapy sources. The relations
formulated in our study for Co-60 and Ir-192 HDR brachyther-
apy using curve fitting can estimate the isodose volume
accurately. Using these relations, the amount of tissue vol-
ume  irradiated can be easily estimated if the TRAK and dose
encompassing the isodose volume are known. Despite a larger
isodose volume in the case of Co-60 than Ir-192 there were
insignificant differences in the bladder and rectal dose due to
these sources.
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